- Home
- OCC vs ANTX Comparison
OCC vs ANTX Comparison
Compare OCC & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- ANTX
- Stock Information
- Founded
- OCC 1983
- ANTX 2017
- Country
- OCC United States
- ANTX United States
- Employees
- OCC N/A
- ANTX N/A
- Industry
- OCC Telecommunications Equipment
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- ANTX Health Care
- Exchange
- OCC Nasdaq
- ANTX Nasdaq
- Market Cap
- OCC 39.9M
- ANTX 37.6M
- IPO Year
- OCC 1996
- ANTX 2022
- Fundamental
- Price
- OCC $4.86
- ANTX $1.27
- Analyst Decision
- OCC
- ANTX Hold
- Analyst Count
- OCC 0
- ANTX 5
- Target Price
- OCC N/A
- ANTX $3.50
- AVG Volume (30 Days)
- OCC 2.0M
- ANTX 143.7K
- Earning Date
- OCC 03-12-2025
- ANTX 11-13-2024
- Dividend Yield
- OCC N/A
- ANTX N/A
- EPS Growth
- OCC N/A
- ANTX N/A
- EPS
- OCC N/A
- ANTX N/A
- Revenue
- OCC $66,674,099.00
- ANTX N/A
- Revenue This Year
- OCC N/A
- ANTX N/A
- Revenue Next Year
- OCC N/A
- ANTX N/A
- P/E Ratio
- OCC N/A
- ANTX N/A
- Revenue Growth
- OCC N/A
- ANTX N/A
- 52 Week Low
- OCC $2.02
- ANTX $0.87
- 52 Week High
- OCC $7.00
- ANTX $21.40
- Technical
- Relative Strength Index (RSI)
- OCC 70.26
- ANTX 44.51
- Support Level
- OCC $4.23
- ANTX $1.34
- Resistance Level
- OCC $5.17
- ANTX $1.28
- Average True Range (ATR)
- OCC 0.50
- ANTX 0.06
- MACD
- OCC 0.03
- ANTX -0.02
- Stochastic Oscillator
- OCC 82.49
- ANTX 21.74
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.